IDiyas

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 11773081 B1

PDFFull Text
Date of Patent:
Oct. 03, 2023

Filed:

Oct. 14, 2022

Pharmaceutical composition for preventing or treating wound, comprising indirubin derivative as active ingredient

Applicant:

Ck Regeon Inc., Seoul, KR;

Inventors:

Kang-Yell Choi, Seoul, KR;

Eunhwan Kim, Gyeonggi-do, KR;

Seol Hwa Seo, Seoul, KR;

Minguen Yoon, Seoul, KR;

Assignee:

CK REGEON INC., Seoul, KR;

Attorneys:

DUANE MORRIS LLP

Gregory M. Lefkowitz

Primary Examiner:

Qiuwen Mi

Int. Cl.
CPC ...
C07D 403/04 (2006.01); A23L 33/105 (2016.01); A23L 33/00 (2016.01); A61K 8/9789 (2017.01); A61P 17/02 (2006.01); A61K 8/06 (2006.01); A61K 8/34 (2006.01); A61K 8/37 (2006.01); A61K 8/49 (2006.01); A61K 8/60 (2006.01); A61K 8/73 (2006.01); A61K 8/92 (2006.01); A61K 9/00 (2006.01); A61K 9/06 (2006.01); A61K 9/107 (2006.01); A61K 31/235 (2006.01); A61K 31/404 (2006.01); A61K 31/7048 (2006.01); A61K 36/754 (2006.01); A61K 47/10 (2017.01); A61K 47/26 (2006.01); A61K 47/40 (2006.01); A61K 47/44 (2017.01); A61Q 19/00 (2006.01);
U.S. Cl.
CPC ...
C07D 403/04 (2013.01); A23L 33/105 (2016.08); A23L 33/40 (2016.08); A61K 8/06 (2013.01); A61K 8/345 (2013.01); A61K 8/37 (2013.01); A61K 8/492 (2013.01); A61K 8/602 (2013.01); A61K 8/604 (2013.01); A61K 8/738 (2013.01); A61K 8/922 (2013.01); A61K 8/9789 (2017.08); A61K 9/0014 (2013.01); A61K 9/0056 (2013.01); A61K 9/06 (2013.01); A61K 9/107 (2013.01); A61K 31/235 (2013.01); A61K 31/404 (2013.01); A61K 31/7048 (2013.01); A61K 36/754 (2013.01); A61K 47/10 (2013.01); A61K 47/26 (2013.01); A61K 47/40 (2013.01); A61K 47/44 (2013.01); A61P 17/02 (2018.01); A61Q 19/00 (2013.01); A23V 2002/00 (2013.01);
Abstract

The present disclosure relates to a composition for preventing or treating wound. The composition according to the present disclosure contains, as an active ingredient, an indirubin derivative alone or one or more selected from a group consisting of an indirubin derivative, anDode extract, methyl vanillate, hesperidin and quercitrin, and thus can be used as a pharmaceutical composition capable of promoting wound healing and reducing scarring not only in a normal state but also in a diabetic state. Furthermore, since the composition exhibits excellent effects in healing diabetic wound as well as general wound, it can be usefully used as a pharmaceutical composition, cosmetic composition or food composition for alleviating, preventing or treating general wound or diabetic wound, or as a veterinary composition for treating diabetic wound.

Find Patent Forward Citations

Loading…